Covid19 Vaccines

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya

AIIMS Director Dr Randeep Guleria recently said data of phase two and three trials of Bharat Biotech's Covaxin on 2 to 18 years age group is expected by September

Delta variant of COVID-19 can infect despite Covishield, Covaxin doses, claims preliminary AIIMS study

The study included 63 people who got breakthrough infections; of which 36 patients received two doses, while 27 had received one dose of vaccine

Kerala, West Bengal report negative wastage of COVID-19 vaccines in May, Jharkhand has highest, says govt data

Punjab, Delhi, Rajasthan, Uttar Pradesh, Gujarat, and Maharashtra reported 7.08%, 3.95%, 3.91%, 3.78% 3.63% and 3.59% respectively

WTO members agree to intensify talks on patent waiver for COVID-19 vaccines, treatments

Since October, the WTO has faced calls led by India and South Africa to ease patents, in what proponents argue will boost production in developing countries of vaccines, treatments needed to battle COVID-19

Covishield produced more antibodies than Covaxin, finds preliminary study

The study, which is a preprint and has not been peer-reviewed, should not be used to guide clinical practice. However, it claimed that seropositivity rates to anti-spike antibodies were significantly higher in Covishield recipients

Serum Institute of India gets DCGI's nod to manufacture Sputnik V in India for test, analysis

The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology in Moscow for developing Sputnik V at its licensed Hadapsar facility

Narendra Modi speaks to Kamala Harris, appreciates US assurance for COVID-19 vaccine supply to India

The US vice-president conveyed that the United States will begin sharing vaccines with India, along with other countries by the end of June

Rahul Gandhi slams Centre's COVID-19 vaccine strategy, blames PM's 'theatrics' for second wave

Addressing an online press conference, the Congress leader said that it's time for Prime Minister Narendra Modi to be a leader and show that he can organise vaccines for everyone

Never exported COVID-19 vaccines at the cost of people in India, says Serum Institute

The company in a statement said that it was committed to doing "everything possible" to support the vaccination drive in the country

Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official

"The data is coming in, and it looks very encouraging that the US-approved vaccines do have effectiveness against this variant called B1617," Dr Francis Collins, Director of the National Institute of Science said